How Expanded Reimbursement for Coronary CTA (CCTA) Could Improve Cardiovascular Outcomes

With better access to tools like CCTA and diagnostic tools that leverage CCTA, clinicians can better support their patients in managing overall cardiovascular health, patients will benefit from less invasive care and enhanced quality of life, and health systems could ultimately see reduced costs and streamlined workflows.  The post How Expanded Reimbursement for Coronary CTA…

Read More

Wheelchair? Hearing Aids? Yes. ‘Disabled’? No Way.

In her house in Ypsilanti, Michigan, Barbara Meade said, “there are walkers and wheelchairs and oxygen and cannulas all over the place.” Barbara, 82, has chronic obstructive pulmonary disease, so a portable oxygen tank accompanies her everywhere. Spinal stenosis limits her mobility, necessitating the walkers and wheelchairs and considerable help from her husband, Dennis, who…

Read More

Prostate Cancer Management – We Need Better Options for Early-Stage Disease

We need to continue investing in research for early stage, localized prostate cancer, develop treatments that balance efficacy with quality-of-life considerations, ensure diverse representation in clinical trials, and listen to patients and incorporate their perspectives into treatment development and decision-making.  The post Prostate Cancer Management – We Need Better Options for Early-Stage Disease appeared first…

Read More